The global “transplantation market” size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The increasing awareness regarding organ donations coupled with government initiatives can have an excellent impact on the global market in the forthcoming years, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020.

An Overview of the Impact of COVID-19 on this Market

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to know more:

https://www.fortunebusinessins....ights.com/transplant

The global “leukemia therapeutics market” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems.

According to a study conducted by the UK Coronavirus Cancer Monitoring Project (UKCCMP), patients with leukemia, multiple myeloma, and lymphoma are highly susceptible to COVID-19 and leukemia patients have twice the chance of dying from the virus. The study found that patients with blood cancer are 57% more likely to experience severe symptoms of COVID-19 than patients with other types of cancers. Given these and other similar findings, the demand for leukemia therapeutics has been soaring during the COVID-19 pandemic, with market players reporting increased sales. Bristol-Myers Squibb, for instance, announced that the sales of Sprycel, its treatment for chronic myeloid leukemia (CML) jumped 14% to USD 521 million in the first quarter of 2020. However, the disruption in the medical supply chain will lead the market to register a lower growth rate of 6.2% and touch a value of USD 16.15 billion in 2020.
Click here to know more:

https://www.fortunebusinessins....ights.com/leukemia-t

Global Recombinant Vaccines | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Recombinant Vaccines Industry, published by Fortune Business Insights. According to this report Global Recombinant Vaccines Marketto rise at healthy Compound Annual Growth Rate by 2028. Market for Recombinant Vaccines Industry is segmented By Product Type (Recombinant Vaccines Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2020-2027

Get Sample PDF Brochure Of Recombinant Vaccines Market Report at:

https://www.fortunebusinessins....ights.com/enquiry/re

Heavy Demand for Vaccines to Escalate Business During Coronavirus

The growing demand for immunization drugs and vaccines due to the extensive spread of the disease amid coronavirus will improve the prospects of the market. The enormous R&D spending by industry players to develop recombinant COVID-19 vaccine will enable speedy expansion of the market in the forthcoming years. For instance, Novavax, a pipeline candidate NVX-CoV2373 is in the phase-1 clinical study against COVID-19. The ongoing clinal trials by pharmaceutical giants for the introduction of an effective COVID vaccine will accelerate the market revenue in the foreseeable future.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Major Recombinant Vaccines Manufacturers covered in the market report include:

GlaxoSmithKline plc. (U.K, Europe)
Merck & Co., Inc (New Jersey, U.S)
Dynavax Technologies (California, U.S)
Pfizer Inc (New York, U.S)
Sanofi S.A (France, Europe)
Serum Institute of India Pvt. Ltd (India, Asia Pacific)
Novartis AG (Switzerland, Europe)
Other Prominent Players
Click here to know more:

https://www.fortunebusinessins....ights.com/industry-r

Recombinant Vaccines Market Analysis 2021:

The global Recombinant Vaccines Market is projected to rise remarkably on account of the increasing number of chronic and acute diseases and the advent of technologically advanced procedures to diagnose them. Recombinant Vaccines is an imaging scanner intensifier used for intraoperative imaging in surgical, orthopaedic, or emergency diagnostic procedures owing to its radiographic abilities.

The increasing number of chronic and acute diseases requiring imaging procedures is a crucial factor propelling the Recombinant Vaccines market growth. This, coupled with a rise in the demand for minimally invasive procedures, is also expected to aid in the expansion of the market. Also, the advent of artificial intelligence in radiology for assisting the discovery of genomic markers will boost the market growth in the coming years.

On the contrary, factors such as high cost of Recombinant Vaccines instruments may pose a significant hindrance to the market in the coming years. Nevertheless, they have a wide variety of applications such as urology, vascular, neurovascular, spinal surgery, and others. The increasing demand for Recombinant Vaccines imaging system from the applications listed above is likely to create lucrative growth opportunities for the market in the coming years.

The world economy is facing rough waters owing to the current pandemic of COVID-19. Most of the import-export businesses are at a halt owing to this pandemic. However, we hope to pass this phase soon with government support and measures. We, at Fortune Business Insights, are offering analytical reports on various markets affected by COVID-19. These reports will help investors chalk out the strategic plans for revenue generation in the coming years.

Recombinant Vaccines Market is likely to rise at a CAGR of 4.6% and reach USD 2,453.3 million by the end of 2027 from a revenue of USD 1,708.1 million generated in the year 2019. The forecast period is set between 2020 to 2027.

Global Influenza Medication Market | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Transrectal Ultrasound Industry, published by Fortune Business Insights. According to this report Global Influenza Medication Market to rise at healthy Compound Annual Growth Rate By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Click here to know more:

https://www.fortunebusinessins....ights.com/industry-r

Major Influenza Medication Manufacturers covered in the market report include:

Alvogen
Amneal Pharmaceuticals LLC
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Seqirus (CSL)
Genentech, Inc.
Macleods Pharmaceuticals Ltd.
Zydus Pharmaceuticals, Inc. (Zydus Cadila)
Lupin Limited
BIOCRYST PHARMACEUTICALS, INC.
Shionogi & Co., Ltd.
Get Sample PDF Brochure Of Influenza Medication Market Report at:

https://www.fortunebusinessins....ights.com/enquiry/sa

Rising Threat from Risk Factors for Influenza to Propel the Market

Prominent among the influenza medication market trends is the threats posed by the risk factors inducing or worsening the effects of influenza infection in humans. According to the CDC, the people most at risk for flu complications include pregnant women, diabetics, asthmatics, adults aged 65 or older, young children, HIV/AIDS patients, cancer patients, and people suffering from chronic lung or heart condition.

For example, congestive heart condition in a person can worsen if she contracts the flu infection. The influenza drugs market growth is further bolstered by the rising prevalence of these risk factors. For instance, the WHO estimates that approximately 235 million people worldwide are living with asthma currently, while 18.1 million new cancer cases were reported worldwide in 2018, the WHO states.

The increasing need for effective waste management is a key factor driving the global “sharps containers market”, says Fortune Business Insights in a report, titled “Sharps Containers Market Size, Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Other Healthcare Providers, Pharmacies, Academic & Research Institutes, Pharmaceutical Companies, and Others), By Usage (Reusable Containers, and Single Use Containers), By Waste Type (Sharps Waste, Infectious Waste, Non-infectious Waste, and Pharmaceutical Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons and Others) and Regional Forecast, 2019-2026.”

The global sharps containers market was valued at USD 449.1 Million in 2018 and is expected to reach USD 624.1 Million by 2026 at a CAGR of 4.2%.As per the report, the rising awareness regarding hazardous waste is expected to aid the growth of the global sharps containers market. For instance, according to World Health Organization, every year, 16 million injections are used worldwide but lack proper disposal of the same. Additionally, out of the total medical waste generated, 85% consists of general, non-hazardous waste and 15% of hazardous waste. This generated waste contains harmful microorganisms that pose a threat to the environment as well as to the healthcare professionals.

The report is focused on offering the best information, an explanatory study consisting of various aspects enabling key players the competence to remain consistent in the global sharps containers market. The report also discusses in-depth about the recent innovations and industrial development in the global sharps containers market

Request a Sample Copy of the Research Report

https://www.fortunebusinessins....ights.com/enquiry/sa

Rising Government Initiatives Regarding Medical Waste Management Will Enable Growth

The rising need for effective medical waste management is expected to boost the global sharps containers market revenue during the forecast period. The increasing government efforts in implementing guidelines for effective disposal of medical waste will stimulate the growth of the global sharps containers market. For instance, World Health Organization (WHO) along with other regulatory bodies in the countries worldwide, have set standard guidelines for disposal and management of biomedical waste. It has become a mandate for all the pharmaceutical companies, research institutes, hospitals, and other healthcare providers to comply with the set of guidelines given by the governing bodies.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Partnership of PureWay With Safe Needle Disposal Will Favor Growth

PureWay, a health-focused organization specializing in medical waste management and compliance solutions, announced its partnership with Safe Needle Disposal, a non-profit devoted to educating the public about safe needle disposal programs. At-home sharps injectors will give access to a user-friendly informational resource and regulatory experts to help answer all their sharps-related questions. It will also responsibly and affordably dispose of needles with new Safe Needle Disposal. The introduction of At-home sharps injectors will support the global sharps containers growth during the forecast period.

Furthermore, the acquisition of Daniels Healthcare Group by MAUSER is expected to create new growth opportunities for the global sharps containers market. For Instance, MAUSER Group announced the acquisition of Daniels Healthcare Group. Daniels Healthcare manufactures and markets medical waste containers for hospitals, surgeries, and the clinical waste industry.

Click here to know more:

https://www.fortunebusinessins....ights.com/industry-r